Phase 2 Bladder Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- You are between 18 and 80 years old (inclusive), of any gender
- Your bladder cancer has not invaded the muscle layer, and is classified as high grade at stage Ta, T1, or Tis
- You have already tried a first-line bladder wash (instillation) treatment that did not work, and your bladder has been kept (or surgery to remove the whole bladder is not suitable for you for another reason)
- During your most recent bladder surgery (TURBT), tissue samples and urine tests came back showing no remaining cancer signs
- Tests of your upper urinary tract (kidneys and ureters) showed no tumors, and you have never had chemotherapy or radiation therapy for bladder cancer
- You are generally active and able to care for yourself (confirm with trial site)
- Your doctor expects you to live for more than 1 year
- Your blood counts, kidney function, liver function, and blood clotting results are all within acceptable ranges (confirm with trial site for specific numbers)
- You agree to use effective contraception during treatment and for at least 3 months afterward
- Any herpes infection you have had ended at least 3 months ago
- You are willing to follow the trial requirements and sign a consent form
Who may not be able to join:
- Your bladder cancer has grown into the muscle layer, or has spread to other parts of the body
- You had complications after your bladder surgery, or bladder wash treatments cannot be carried out for you
- You have a known allergy to GM-CSF products or to any ingredient in the study drug
- You have a serious medical condition, such as severe heart disease, stroke-related disease, uncontrolled diabetes, uncontrolled high blood pressure, severe infection, or an active stomach or bowel ulcer
- You are expected to need chemotherapy or radiation therapy during the study period
- You currently have an active infection, an unexplained fever above 38.5°C, or an ongoing urinary or bladder infection that has not fully cleared (unless it was treated with antibiotics and resolved at least 7 days after finishing the course)
- You have a condition that weakens your immune system (such as HIV), an active hepatitis B infection with detectable virus levels, or active hepatitis C infection
- You are currently pregnant or breastfeeding
- You have taken another experimental drug or antiviral treatment within the past 4 weeks
- You have taken immune-suppressing medications (such as cyclosporine, tacrolimus, or antithymocyte globulin) in the past 3 months
- You have taken part in a cancer vaccine trial (such as dendritic cell therapy or heat shock vaccine) in the past 12 months
- You have a history of substance abuse, alcohol dependency, or drug abuse
- You have been diagnosed with another cancer in the past 5 years, with some exceptions for certain low-risk or successfully treated cancers (confirm with trial site)
- You have an active autoimmune disease, or a history of one that may come back — though certain manageable conditions such as type 1 diabetes, controlled low thyroid, controlled celiac disease, or skin conditions not needing systemic treatment may be exceptions (confirm with trial site)
- You have used steroid medications as a treatment within the past 14 days, or regularly take other immune-suppressing medicines — though some limited uses such as inhalers, eye drops, or short-term preventive steroids may be exceptions (confirm with trial site)
- The trial doctors have any other concern that makes participation unsuitable for you
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: 13601332989
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
AEs; Relapse Free Survival Rate at 6 months; Relapse Free Survival Rate at 12 months; Rate of disease progression
Can't join this trial?
Data last synced from ClinicalTrials.gov: 23 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.